Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Strategy

<< Previous

Bullboard Posts

Next >>

Comment by mkailison Dec 01, 2021 8:34pm

476 Views

Post# 34188039

RE:RE:RE:RE:RE:RE:Strategy

When you contribute to a TFSA, it's important to be mindful of the TFSA contribution limit – the maximum amount that you can contribute to a TFSA in any given year. The annual TFSA contribution limit for 2021 is $6,000 and you can carry forward unused contribution room from previous years.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for June 25, 2024